October 12th, 2026FDA Approves Once-Monthly Olanzapine Injection for Adults with SchizophreniaTeva Pharmaceuticals’ new olanzapine option is the first once-monthly subcutaneous injectable on the market for schizophrenia.Read more
October 12th, 2026Indoor Air Sampling Could Revolutionize Pneumococcal Disease SurveillanceThe novel tool can be used to inform vaccine policy, monitor impact, and essentially strengthen overall surveillance.Read more
October 12th, 2026American Pharmacists Month: The Many Career Paths US Pharmacists ExploreMelissa McGivney, PharmD, FAPhA, FCCP, discusses her career journey from her local pharmacy to a national leadership role with the American Pharmacists Association.Read more
October 11th, 2026Community-Based Equity Strategies Best for Improving Vaccine UptakeResearchers evaluate peer-reviewed literature on interventions to improve vaccine uptake among thousands of US adults studied between 2010 and 2015.Read more
October 10th, 2026From Binder to Action: Making Infectious Disease Outbreak Plans OperationalInfectious disease readiness depends on rehearsed workflows, bidirectional public health communication, and rapid access to care.Read more
October 9th, 2026Pharmacist Pain Management Clinics: The Expert as the Pain CoachPharmacist pain clinics typically focus on comprehensive medication management involving the entire patient scenario.Read more
October 9th, 2026Serotype 34 Causes Pneumococcal Meningitis in Child With Cochlear ImplantsA case shows a suspected recurrence of pneumococcal disease that ended with removal of one cochlear implant and replacement of the other.Read more
October 9th, 2026Retatrutide Delivers 20.8% Weight Loss in Adults With Type 2 DiabetesDetailed phase 3 data show retatrutide lowered body weight and A1C over 80 weeks for patients with diabetes and obesity.Read more